Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model-Reference-Cited by-同舟云学术

Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model

Published:2017-11-14 Issue:11 Volume:12 Page:e0188050
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bakopoulos Anargyros,Kapelouzou Alkistis^ORCID,Tsilimigras Diamantis I.,Katsimpoulas Michalis,Schizas Dimitrios,Aravanis Chrysostomos,Balafas Evaggelos,Mavroidis Manolis,Pavlakis Kitty,Machairas Anastasios,Liakakos Theodore

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);M Singer;JAMA,2016

2. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008;RP Dellinger;Intensive Care Med,2008

3. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care;DC Angus;Crit Care Med,2001

4. Cardiovascular management of septic shock;RP Dellinger;Crit Care Med,2003

5. The epidemiology of sepsis in the United States from 1979 through 2000;GS Martin;N Engl J Med,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Functioned Hexapeptide‐Coated Lipid‐Core Nanomicelles Suppress Toll‐Like Receptor‐Mediated Inflammatory Responses through Endotoxin Scavenging and Endosomal pH Modulation;Advanced Science;2023-04-20

2. Activation of TLRs Triggers GLP-1 Secretion in Mice;International Journal of Molecular Sciences;2023-03-10

3. Role of RIPK1 in the pathogenesis of acute respiratory distress syndrome;BIOCELL;2023

4. Attenuation of the Severity of Acute Respiratory Distress Syndrome by Pomiferin through Blocking Inflammation and Oxidative Stress in an AKT/Foxo1 Pathway-Dependent Manner;Oxidative Medicine and Cellular Longevity;2022-11-26

5. The Yin and Yang of toll-like receptors in endothelial dysfunction;International Immunopharmacology;2022-07